Highnoon Laboratories Ltd (HINL)

Currency in PKR
913.44
-26.73(-2.84%)
Closed·
High dividend Yield
HINL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
901.10944.99
52 wk Range
755.561,241.00
Key Statistics
Bid/Ask
913.44 / 924.90
Prev. Close
940.17
Open
944.99
Day's Range
901.1-944.99
52 wk Range
755.56-1,241
Volume
21.56K
Average Volume (3m)
37.24K
1-Year Change
0.8802%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HINL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1,121.00
Upside
+22.72%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 1,121.00
(+22.72% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Feb 25, 2026
EPS / Forecast
27.33 / --
Revenue / Forecast
7.4B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 79.68%
Dividend Yield
5.27%
Industry Median 4.09%
Annualized payout
50.00
Paid unevenly
5-Years Growth
+38.53%
Growth Streak

HINL Income Statement

Compare HINL to Peers and Sector

Metrics to compare
HINL
Peers
Sector
Relationship
P/E Ratio
11.5x14.4x−0.5x
PEG Ratio
0.590.120.00
Price/Book
3.3x1.5x2.6x
Price / LTM Sales
1.7x1.7x3.2x
Upside (Analyst Target)
22.7%33.2%47.8%
Fair Value Upside
Unlock27.8%6.7%Unlock

Highnoon Laboratories Limited, together with its subsidiaries, manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products. It offers products in various therapeutic areas, including allergy, anti-infective, cardiology, gastroenterology, metabolic, musculoskeletal, obstetrics and gynaecology, paediatrics, allergy, respiratory, and urology; and generic products under various brands. The company operates in Pakistan, Afghanistan, the United Arab Emirates, France, Kenya, Iraq, Cambodia, Tanzania, Dubai, Sudan, and internationally. Highnoon Laboratories Limited was incorporated in 1984 and is headquartered in Lahore, Pakistan.

Employees
2563
Market
Pakistan

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.15M5.94%2.88B
Other Institutional Investors
7.87M14.86%7.19B
Public Companies & Retail Investors
41.96M79.19%38.33B
Total
52.98M100.00%48.4B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Pharmatec Investments Limited8.34%4,416,2424,033,972
State Life Insurance Corporation of Pakistan Limited5.40%2,861,9532,614,222

People Also Watch

734.90
HALE
-1.46%
181.71
AGPL
-0.29%
274.02
ENGO
-1.77%
726.09
PACK
+1.09%
9,401.8
RAMZ
-0.92%

FAQ

What Is the Highnoon Labs (HINL) Stock Price Today?

The Highnoon Labs stock price today is 913.44 PKR.

What Stock Exchange Does Highnoon Labs Trade On?

Highnoon Labs is listed and trades on the Karachi Stock Exchange.

What Is the Stock Symbol for Highnoon Labs?

The stock symbol for Highnoon Labs is "HINL."

Does Highnoon Labs Pay Dividends? What’s The Current Dividend Yield?

The Highnoon Labs dividend yield is 5.32%.

What Is the Highnoon Labs Market Cap?

As of today, Highnoon Labs market cap is 48.40B PKR.

What Is Highnoon Labs's Earnings Per Share (TTM)?

The Highnoon Labs EPS (TTM) is 79.68.

When Is the Next Highnoon Labs Earnings Date?

Highnoon Labs will release its next earnings report on Jun 03, 2026.

From a Technical Analysis Perspective, Is HINL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Highnoon Labs Stock Split?

Highnoon Labs has split 21 times.

How Many Employees Does Highnoon Labs Have?

Highnoon Labs has 2563 employees.

What is the current trading status of Highnoon Labs (HINL)?

As of May 02, 2026, Highnoon Labs (HINL) is trading at a price of 913.44 PKR, with a previous close of 940.17 PKR. The stock has fluctuated within a day range of 901.10 PKR to 944.99 PKR, while its 52-week range spans from 755.56 PKR to 1,241.00 PKR.

What Is Highnoon Labs (HINL) Price Target According to Analysts?

The average 12-month price target for Highnoon Labs is 1,121.00 PKR, with a high estimate of 1121 PKR and a low estimate of 1121 PKR. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +22.72% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.